| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2007-01-29 |
Hawaii Biotech
Life Science Honolulu, Hawaii www.hibiotech.com Hawaii Biotech is a biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. Hawaii Biotech was founded in 1982 and is based in Honolulu, Hawaii. |
Venture |
Advantage Capital Partners
|
- | ||
| 2006-05-01 |
Cardax Pharmaceuticals, Inc.
Life Science Honolulu, Hawaii www.cardaxpharma.com Cardax Pharmaceuticals, Inc. is a developer of proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles - including cardiovascular disease, hepatitis, macular degeneration and many cancers. |
Venture |
Advantage Capital Partners
|
- | ||
| 2005-11-03 |
Nanopoint
Medical Products Honolulu, Hawaii Nanopoint develops and markets unique cellular imaging systems for the life sciences market. Nanopoint's cellTRAY®-based solutions are miniaturized cell culture and imaging systems for live cell-based assays. Nanopoint was founded in 2002 and is based in Honolulu, Hawaii. |
Venture |
Advantage Capital Partners
|
- | ||
| 2005-03-24 |
Band Digital, Inc.
Information Technology Chicago, Hawaii www.banddigital.com Whittman-Hart was an IT consulting and services firm focusing on middle-market customers. The company created an expansion model that enabled it to replicate its core service offerings, taking it from a single location to a total of 21 offices. |
Venture
|
TPE Boulder
Topspin Partners LBO
|
- | ||
| 2003-12-01 |
Hoku Corp.
Technology Hardware Honolulu, Hawaii www.hokucorp.com Hoku Corp. is a developer of fuel cell membrane technology. The company's primary focus is a new membrane for use in Proton Exchange Membrane (PEM) fuel cells. The Hoku Membrane offers the potential for substantially better performance than today's leading technologies, while reducing product costs by as much as 90%. The company is also working on an alternative membrane design for use in direct methanol fuel cells, as well as a new design for a low operating temperature fuel cell. |
Venture |
Advantage Capital Partners
|
- | ||
| Avg |
$13
0.0x EBITDA 0.0x REVENUE |
|||||
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.